Skip to main content

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Inmune Bio, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of INMB: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders5257+5
Shares2.74M4.57M+1.83M (+66.7%)
Value$32.2M$40.3M+$8.10M (+25.1%)

New holders (19)

Institutions that held Inmune Bio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to INMB in Q2 2024
InstitutionSharesValue% of portfolio
CVI Holdings, LLC596,372$5.26M4.54%
Praetorian PR LLC485,000$4.28M1.57%
Raymond James Financial Services Advisors, Inc.227,534$2.01M0.00%
Charles Schwab Investment Management Inc37,275$328.8K0.00%
Corton Capital Inc.20,545$181.2K0.10%
Nuveen Asset Management, LLC16,518$145.7K0.00%
Rhumbline Advisers13,773$121.5K0.00%
New York State Common Retirement Fund11,600$102.3K0.00%
Alpine Global Management, LLC11,559$102.0K0.02%
Corebridge Financial, Inc.6,567$58.0K0.00%
Simplex Trading, LLC5,786$51.0K0.00%
JPMorgan Chase & Co5,202$45.9K0.00%
Barclays PLC4,138$36.5K0.00%
Redwood Wealth Management Group, LLC2,200$19.4K0.01%
Legal & General Group Plc1,358$12.0K0.00%
Ameritas Investment Partners, Inc.1,196$10.5K0.00%
California State Teachers Retirement System885$7.81K0.00%
BNP Paribas Arbitrage, SA879$7.75K0.00%
Amalgamated Bank422$4.00K0.00%

Sold out (14)

Institutions that held Inmune Bio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.